GH Research Announces Global Pivotal Program Plans for GH001 and GH002

GH Research PLC provided updates on its clinical-stage biopharmaceutical programs. The company announced a response from the FDA regarding its Invest...
Home/KnloSights/Clinical Trial Updates/GH Research Announces Global Pivotal Program Plans for GH001 and GH002